Thursday, March 13, 2014 | 6:30 PM - 8:00 PM
Speakers: Charles Camarda (NASA), Dave Mosher (Popular Science), Sara Zwart (NASA)
Going to space is the ultimate adventure, the tiniest margin of error can determine if a mission is a success or a failure. But other concerns, like what to eat for dinner, are also important to those who venture into the final frontier.
Thursday, March 20, 2014 | 6:00 PM - 8:30 PM
Speaker: Sean F. Brady (The Rockefeller University), Steven Edgar (MIT), Justin Nodwell (University of Toronto), Kang Zhou (MIT)
Secondary metabolites or idiolites play many roles in biological systems, including communication, defense and signaling. This symposium takes a systems biology approach to explore their biological effects and potential benefits for human health.
Friday, March 28, 2014 | 9:00 AM - 5:00 PM
Keynote Speakers: Rayid Ghani (University of Chicago) and Brian Kingsbury (IBM), Jorge Nocedal (Northwestern University)
Chief Data Scientist for the 'Obama for America' 2012 re-election campaign, and other experts, explore the latest innovations in harnessing the power of big data through machine learning.
Tuesday, June 3, 2014 | 9:30 AM - 2:30 PM
Keynote Speaker: Michael Marletta (The Scripps Research Institute)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Michael Marletta of the Scripps Research Institute and a poster session.
Tuesday, January 28, 2014 | 8:30 AM - 4:30 PM
Speakers: Nahor Haddish-Berhane (Pfizer), Sara Hurvitz (UCLA Medical Center), Omar Kabbarah (Genentech Inc.), Peter D. Senter (Seattle Genetics, Inc.), Dhaval K. Shah (The State University of New York at Buffalo), Stacey S. Shord (Food and Drug Administration), Melissa M. Schutten (Genentech Inc.), and Puja Sapra (Pfizer), Alan Wahl (Ambrx)
Antibody-drug conjugates (ADCs) promise safer, more effective therapies than standard anti-cancer drugs. This symposium highlights linker-payload and coupling chemistries, ADC development, biomarker and patient selection, and regulatory perspectives.
Wednesday, December 11, 2013 | 12:00 PM - 4:00 PM
Speakers: T. Eric Ballard (Pfizer Worldwide Research and Development), Joseph M. Fox (University of Delaware), Howard C. Hang (The Rockefeller University), Minkui Luo (Memorial Sloan-Kettering Cancer Center), Lisa Shah (SUNY Stony Brook)
Innovations in chemistry often lead to breakthroughs in biology and medicine. This symposium highlights advances in bioorthogonal chemistry, affording opportunities to explore biology and facilitating the synthesis of diagnostics and therapeutics.
Thursday, November 21, 2013 | 8:00 AM - 5:00 PM
Keynote Speaker: Sally Tinkle (IDA/Science and Technology Policy Institute)
Featured Speakers: Yechezkel (Chezy) Barenholz (Hebrew University-Hadassah Medical School), Raj Bawa (Bawa Biotech LLC and Rensselaer Polytechnic Institute), Gerrit Borchard (University of Geneva, University of Lausanne), Ricardo Carvajal (Hyman, Phelps & McNamara, P.C.), Neil Desai (Abraxis Bioscience, A wholly owned subsidiary of Celgene Corporation), Rogério Gaspar (University of Lisbon), Patrick Hunziker (University Hospital Basel), Laurent Levy (Nanobiotix), Scott E. McNeil (Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd. and University of Basel), Ritu Nalubola (US Food and Drug Administration), Lawrence Tamarkin (Cytimmune)
Explore regulatory challenges in the nascent field of nanomedicines including the relevance and adequacy of existing frameworks, availability and expertise of regulators, and safety concerns.
Thursday, October 17, 2013 | 7:00 PM - 8:30 PM
Moderator: Carl Zimmer (Science Writer)
Speakers: Amy Lee Robinson (Eyewire), Jonathan Fisher (Rockefeller University, Blavatnik Award Winner), Oliver Medvedik (GenSpace)
Join the Academy and the Imagine Science Film Festival for a discussion that explores how data—from the huge data sets generated by genomics to a map of the brain—can be uniquely captured in the medium of film.
Keynote Speaker: Robert J. Greenberg (Alfred E. Mann Foundation)
This eBriefing explores the translation of neurotechnologies into new treatment options for neurological and psychiatric diseases.
Edited by Annals of the New York Academy of Sciences
This Annals volume presents a collection of papers stemming from two conferences: (1) Evolutionary Dynamics and Information Hierarchies in Biological Systems: Aspen Center for Physics workshop; and (2) Cracking the Neural Code: Third Annual Aspen Brain Forum.
Keynote Speakers: Omid Farokhzad (Brigham and Women's Hospital, Harvard Medical School) and Ralph Weissleder (Massachusetts General Hospital)
This eBriefing discusses nanoparticles, which have recently emerged at the forefront of cancer therapies, highlighting their uses in cancer diagnosis, treatment, and prevention.
Edited by Annals of the New York Academy of Sciences
This Annals issue explores how large data sets can be harnessed to improve energy management in the built environment.
Neil deGrasse Tyson hosts the 2010 Isaac Asimov debate at the Hayden Planetarium. He and five panelists debate whether NASA should bother going back to the moon, or just focus on Mars instead.
Famed screenwriter Charlie Kaufman and theoretical physicist Brian Greene dissect time as we know it. What is the smallest unit of time, and what does it look like? For starters, you should stop looking at the clock, and start looking at the universe.
Award-winning filmmaker Shekhar Kapur and astrophysicist Piet Hut discuss what chaos is and what it means when it comes to the universe.
November 21, 2009
Graduate students from around the New York metropolitan area recently organized a symposium spotlighting some of the most exciting local work in soft and hard condensed matter physics. This webinar archive collects all the presentations.
April 28, 2009
Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.
April 22, 2009
Green architects and engineers are working to balance energy consumption and generation at the level of individual buildings. But how do we define "zero" energy, and how can we reach this goal?
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.